Non-invasive Stimulation of the Glymphatic System for Slowing Cognitive Decline

Last updated: May 5, 2026
Sponsor: University of Wisconsin, Madison
Overall Status: Active - Recruiting

Phase

N/A

Condition

Mild Cognitive Impairment

Dementia

Neurologic Disorders

Treatment

Magnetic Resonance Imaging (MRI)

MAGNUS scanner

Functional near-infrared spectroscopy (fNIRS)

Clinical Study ID

NCT07044596
2023-0970
Protocol Version 3/10/25
Protocol Version 3/31/26
SMPH/NEURO SURG/NEURO SURG
A535700
  • Ages 20-85
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The purpose of this research is to demonstrate that mild stimulation of a nerve (trigeminal nerve) in the head can modulate blood flow in the brain. The modulated blood flow will restore the flow of cerebrospinal fluid (CSF) and this in turn can help improve waste clearance in the brain and prevent build up that may lead to disease.

Eligibility Criteria

Inclusion

Inclusion Criteria - Healthy Participants :

  • Age 20-85 years

  • Willing and able to undergo all procedures

  • Free of any neurological (e.g., epilepsy, stroke, Parkinson's, brain tumors, moderate or severe traumatic brain injury), neuropsychiatric (e.g., schizophrenia, substance abuse, clinical depression), or developmental (e.g., autism, ADHD) or any other medical condition at the discretion of the PI and co-investigators

Inclusion Criteria - mTBI :

  • Age 20-65

  • Diagnosed with mild traumatic brain injury and be within 1-52 weeks post-injury

  • Willing and able to undergo all procedures

Exclusion Criteria - Healthy Participants:

  • Contraindication to MRI

  • Known allergies to common electrode materials

Exclusion Criteria - mTBI:

  • Contraindications for MRI

  • Known allergies to common electrode materials

  • Candidates currently on cardiovascular medications which, in the opinion of the investigators, would introduce a confounding factor to glymphatic system function (i.e. ACE-inhibitors, angiotensin receptor blockers, calcium channel blockers)

  • Candidates who have chronic infectious diseases (e.g. hepatitis, HIV, TB)

  • Candidates diagnosed with small vessel disease, vascular associated dementia (e.g. VCID), or renal disease

  • Candidates retinopathies or neuropathies that, in the opinion of the investigators, would prevent them from being able to complete the study or would introduce a confounding factor to glymphatic system function

  • Candidates with neurological disorders other than those attributed to their primary diagnosis (e.g. MS, PD, ALS, AD or other dementia, uncontrolled pain)

  • Candidates who have had a penetrating injury, craniotomy (with the exception of a burr hole (trephination) for resolution of acute subdural hematoma), or refractory subdural hematoma

  • Candidates with a history of seizures (except those in the acute or post-acute phases and are controlled)

  • Candidates who experienced a loss of consciousness greater than 24 hours as a result of their TBI

  • Candidates who, in the opinion of the investigators, are unable to feel a sensory referred sensation from the stimulation or successfully complete the electrode placement and testing fNIRs

Study Design

Total Participants: 55
Treatment Group(s): 4
Primary Treatment: Magnetic Resonance Imaging (MRI)
Phase:
Study Start date:
November 13, 2025
Estimated Completion Date:
December 31, 2026

Study Description

The goal of this clinical trial is to demonstrate that non-invasive stimulation of the trigeminal nerve can be used to restore blood flow and consequently modulate CSF flow into the brain parenchyma to facilitate brain waste clearance that is impaired in patients with AD. This study will collect brain MRI data on 20 healthy cognitively unimpaired adults receiving intermittent trigeminal nerve branch (V1) stimulation. Participants with recent mild traumatic brain injuries will also be enrolled to establish feasibility within a clinically relevant population.

Connect with a study center

  • University of Wisconsin - Madison

    Madison, Wisconsin 53705
    United States

    Active - Recruiting

  • University of Wisconsin - Madison

    Madison 5261457, Wisconsin 5279468 53705
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.